The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

The purpose of this study is to determine whether memantine will enhance the therapeutic of effect on depression and prevent memory and other cognitive problems caused by ECT.

Key facts

Study ID

NCT00988663

Run by

Jerrry L Lewis

People needed

0

Starts

2009-11-01

Expected to finish

2009-11-01

Last updated by the study team

2017-03-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Meets criteria for Major Depressive disorder

You may not qualify if…

• Neurological disease
• Mental retardation
• Seizure disorder

Where it is running

• University of Iowa hosptitals and clinic — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.